In order to explore whether NQO1 was involved in the cytotoxicity of scopoletin to cholangiocarcinoma cells, Khunluck also tested the cytotoxicity of scopoletin to cholangiocarcinoma cells that had been introduced with NQO1 siRNA and found that the cytotoxicity was reduced. Here, NQO1 is linked to cholangiocarcinoma.